Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genome-wide association study of event-free survival in follicular lymphoma patients treated with front-line immunochemotherapy.

Blood cancer journal - 9 Jan 2026

Ghesquières Hervé, Drouet Youenn, Slager Susan L, Morschhauser Franck, Julia Edith, Galimberti Sara, Robinson Dennis, Larson Melissa C, Testard Quentin, Tesson Bruno, Deleuze Jean-François, Boland Anne, Thomas Emilie, Lasset Christine, Novak Anne J, Xerri Luc, Luminari Stefano, Verney Aurelie, Laurent Camille, Rimsza Lisa M, Habermann Thomas M, Federico Massimo, Link Brian K, Salles Gilles, Cerhan James R

Abstract excerpt

Genome-wide association studies (GWAS) have identified germline genetic variants for follicular lymphoma (FL) susceptibility. We conducted a GWAS of prognosis in FL patients to identify genetic predictors of event-free survival (EFS) as well as failure within the first 24 months after treatment initiation (EFS24) using patients treated with rituximab-based immunochemotherapy from three clinical trials and one...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antineoplastic Combined Chemotherapy Protocols

Share to Disease-Free Survival

Share to Genome-Wide Association Study

Share to Immunotherapy

Share to Lymphoma, Follicular

Share to Prognosis

Share to Rituximab

Source

Open in PubMed Open full text

Identifiers

PMID: 41513626
DOI: 10.1038/s41408-025-01435-1
PMCID: PMC12876897

Genes

EFS
FETUB
HRG

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genome-wide association study of event-free survival in follicular lymphoma patients treated with front-line immunochemotherapy.PMID 41513626Read ↗

Integrative genomic and transcriptomic analysis reveals genetic alterations associated with the early progression of follicular lymphoma.Semantic proximity Read ↗

Follicular lymphoma genomics.Semantic proximity Read ↗

From genetics to the clinic: a translational perspective on follicular lymphoma.Semantic proximity Read ↗

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.Semantic proximity Read ↗

A comprehensive evaluation of the role of genetic variation in follicular lymphoma survival.Semantic proximity Read ↗

Advances in the multi-omics landscape of follicular lymphomaSemantic proximity Read ↗

Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303.Semantic proximity Read ↗

The promises and challenges of using gene mutations for patient stratification in follicular lymphoma.Semantic proximity Read ↗

Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016Semantic proximity Read ↗

Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region.Semantic proximity Read ↗

Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphoma.Semantic proximity Read ↗

Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.